nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—PPAT—Fluorouracil—urinary bladder cancer	0.467	1	CbGbCtD
L-Glutamine—TGM5—penis—urinary bladder cancer	0.0185	0.087	CbGeAlD
L-Glutamine—TGM3—penis—urinary bladder cancer	0.014	0.0659	CbGeAlD
L-Glutamine—TGM4—prostate gland—urinary bladder cancer	0.00638	0.03	CbGeAlD
L-Glutamine—TGM4—epithelium—urinary bladder cancer	0.00469	0.022	CbGeAlD
L-Glutamine—TGM1—prostate gland—urinary bladder cancer	0.00358	0.0168	CbGeAlD
L-Glutamine—QARS—Azacitidine—Gemcitabine—urinary bladder cancer	0.00356	1	CbGdCrCtD
L-Glutamine—GLS2—prostate gland—urinary bladder cancer	0.00307	0.0144	CbGeAlD
L-Glutamine—NADSYN1—prostate gland—urinary bladder cancer	0.00307	0.0144	CbGeAlD
L-Glutamine—Glutathione—GSTO2—urinary bladder cancer	0.00305	0.311	CrCbGaD
L-Glutamine—Glutathione—GSTZ1—urinary bladder cancer	0.00305	0.311	CrCbGaD
L-Glutamine—CCBL1—prostate gland—urinary bladder cancer	0.00281	0.0132	CbGeAlD
L-Glutamine—GATB—prostate gland—urinary bladder cancer	0.00281	0.0132	CbGeAlD
L-Glutamine—GLS—prostate gland—urinary bladder cancer	0.00265	0.0125	CbGeAlD
L-Glutamine—TGM2—prostate gland—urinary bladder cancer	0.00262	0.0123	CbGeAlD
L-Glutamine—CTPS1—prostate gland—urinary bladder cancer	0.00247	0.0116	CbGeAlD
L-Glutamine—GMPS—prostate gland—urinary bladder cancer	0.00247	0.0116	CbGeAlD
L-Glutamine—GFPT2—prostate gland—urinary bladder cancer	0.00242	0.0114	CbGeAlD
L-Glutamine—PFAS—prostate gland—urinary bladder cancer	0.00242	0.0114	CbGeAlD
L-Glutamine—CCBL1—seminal vesicle—urinary bladder cancer	0.00238	0.0112	CbGeAlD
L-Glutamine—TGM5—vagina—urinary bladder cancer	0.00218	0.0103	CbGeAlD
L-Glutamine—F13A1—prostate gland—urinary bladder cancer	0.00218	0.0102	CbGeAlD
L-Glutamine—CTPS1—seminal vesicle—urinary bladder cancer	0.00209	0.00981	CbGeAlD
L-Glutamine—QARS—prostate gland—urinary bladder cancer	0.00207	0.00971	CbGeAlD
L-Glutamine—PFAS—seminal vesicle—urinary bladder cancer	0.00205	0.00963	CbGeAlD
L-Glutamine—GFPT2—seminal vesicle—urinary bladder cancer	0.00205	0.00963	CbGeAlD
L-Glutamine—TGM1—female reproductive system—urinary bladder cancer	0.00195	0.00918	CbGeAlD
L-Glutamine—TGM2—epithelium—urinary bladder cancer	0.00193	0.00905	CbGeAlD
L-Glutamine—CCBL1—renal system—urinary bladder cancer	0.00192	0.00901	CbGeAlD
L-Glutamine—GATB—renal system—urinary bladder cancer	0.00192	0.00901	CbGeAlD
L-Glutamine—CAD—prostate gland—urinary bladder cancer	0.00191	0.00896	CbGeAlD
L-Glutamine—CCBL1—urethra—urinary bladder cancer	0.00188	0.00885	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—urinary bladder cancer	0.00186	0.00872	CbGeAlD
L-Glutamine—F13A1—seminal vesicle—urinary bladder cancer	0.00184	0.00864	CbGeAlD
L-Glutamine—GLS—renal system—urinary bladder cancer	0.00181	0.00849	CbGeAlD
L-Glutamine—TGM2—renal system—urinary bladder cancer	0.00179	0.00839	CbGeAlD
L-Glutamine—PPAT—prostate gland—urinary bladder cancer	0.00177	0.00831	CbGeAlD
L-Glutamine—TGM1—vagina—urinary bladder cancer	0.00177	0.0083	CbGeAlD
L-Glutamine—QARS—seminal vesicle—urinary bladder cancer	0.00175	0.00821	CbGeAlD
L-Glutamine—GFPT2—smooth muscle tissue—urinary bladder cancer	0.00172	0.00806	CbGeAlD
L-Glutamine—GMPS—renal system—urinary bladder cancer	0.00168	0.0079	CbGeAlD
L-Glutamine—CTPS1—renal system—urinary bladder cancer	0.00168	0.0079	CbGeAlD
L-Glutamine—NADSYN1—female reproductive system—urinary bladder cancer	0.00167	0.00786	CbGeAlD
L-Glutamine—GLS2—female reproductive system—urinary bladder cancer	0.00167	0.00786	CbGeAlD
L-Glutamine—TGM3—vagina—urinary bladder cancer	0.00166	0.00778	CbGeAlD
L-Glutamine—CTPS1—urethra—urinary bladder cancer	0.00165	0.00776	CbGeAlD
L-Glutamine—GMPS—urethra—urinary bladder cancer	0.00165	0.00776	CbGeAlD
L-Glutamine—GFPT2—renal system—urinary bladder cancer	0.00165	0.00776	CbGeAlD
L-Glutamine—SLC1A5—prostate gland—urinary bladder cancer	0.00164	0.00769	CbGeAlD
L-Glutamine—PFAS—urethra—urinary bladder cancer	0.00162	0.00762	CbGeAlD
L-Glutamine—GFPT2—urethra—urinary bladder cancer	0.00162	0.00762	CbGeAlD
L-Glutamine—CAD—seminal vesicle—urinary bladder cancer	0.00161	0.00758	CbGeAlD
L-Glutamine—GATB—female reproductive system—urinary bladder cancer	0.00154	0.00722	CbGeAlD
L-Glutamine—GLS2—vagina—urinary bladder cancer	0.00151	0.00711	CbGeAlD
L-Glutamine—NADSYN1—vagina—urinary bladder cancer	0.00151	0.00711	CbGeAlD
L-Glutamine—PPAT—seminal vesicle—urinary bladder cancer	0.0015	0.00703	CbGeAlD
L-Glutamine—F13A1—renal system—urinary bladder cancer	0.00148	0.00696	CbGeAlD
L-Glutamine—SLC7A8—prostate gland—urinary bladder cancer	0.00147	0.00693	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—urinary bladder cancer	0.00146	0.00688	CbGeAlD
L-Glutamine—F13A1—urethra—urinary bladder cancer	0.00146	0.00684	CbGeAlD
L-Glutamine—GLS—female reproductive system—urinary bladder cancer	0.00145	0.0068	CbGeAlD
L-Glutamine—TGM2—female reproductive system—urinary bladder cancer	0.00143	0.00672	CbGeAlD
L-Glutamine—QARS—renal system—urinary bladder cancer	0.00141	0.00662	CbGeAlD
L-Glutamine—ASNS—prostate gland—urinary bladder cancer	0.0014	0.0066	CbGeAlD
L-Glutamine—CCBL1—vagina—urinary bladder cancer	0.00139	0.00653	CbGeAlD
L-Glutamine—GATB—vagina—urinary bladder cancer	0.00139	0.00653	CbGeAlD
L-Glutamine—SLC1A5—seminal vesicle—urinary bladder cancer	0.00139	0.00651	CbGeAlD
L-Glutamine—QARS—urethra—urinary bladder cancer	0.00138	0.0065	CbGeAlD
L-Glutamine—GMPS—female reproductive system—urinary bladder cancer	0.00135	0.00633	CbGeAlD
L-Glutamine—CTPS1—female reproductive system—urinary bladder cancer	0.00135	0.00633	CbGeAlD
L-Glutamine—PFAS—female reproductive system—urinary bladder cancer	0.00132	0.00622	CbGeAlD
L-Glutamine—GFPT2—female reproductive system—urinary bladder cancer	0.00132	0.00622	CbGeAlD
L-Glutamine—GLS—vagina—urinary bladder cancer	0.00131	0.00615	CbGeAlD
L-Glutamine—CAD—urethra—urinary bladder cancer	0.00128	0.006	CbGeAlD
L-Glutamine—GMPS—vagina—urinary bladder cancer	0.00122	0.00573	CbGeAlD
L-Glutamine—CTPS1—vagina—urinary bladder cancer	0.00122	0.00573	CbGeAlD
L-Glutamine—SLC1A5—epithelium—urinary bladder cancer	0.0012	0.00565	CbGeAlD
L-Glutamine—PFAS—vagina—urinary bladder cancer	0.0012	0.00562	CbGeAlD
L-Glutamine—GFPT2—vagina—urinary bladder cancer	0.0012	0.00562	CbGeAlD
L-Glutamine—ASNS—seminal vesicle—urinary bladder cancer	0.00119	0.00558	CbGeAlD
L-Glutamine—F13A1—female reproductive system—urinary bladder cancer	0.00119	0.00558	CbGeAlD
L-Glutamine—SLC1A5—smooth muscle tissue—urinary bladder cancer	0.00116	0.00545	CbGeAlD
L-Glutamine—GLUL—prostate gland—urinary bladder cancer	0.00115	0.00539	CbGeAlD
L-Glutamine—TGM1—lymph node—urinary bladder cancer	0.00114	0.00537	CbGeAlD
L-Glutamine—QARS—female reproductive system—urinary bladder cancer	0.00113	0.0053	CbGeAlD
L-Glutamine—SLC1A5—renal system—urinary bladder cancer	0.00112	0.00524	CbGeAlD
L-Glutamine—SLC1A5—urethra—urinary bladder cancer	0.0011	0.00515	CbGeAlD
L-Glutamine—Glutathione—GPX1—urinary bladder cancer	0.00109	0.112	CrCbGaD
L-Glutamine—F13A1—vagina—urinary bladder cancer	0.00107	0.00504	CbGeAlD
L-Glutamine—CAD—female reproductive system—urinary bladder cancer	0.00104	0.00489	CbGeAlD
L-Glutamine—QARS—vagina—urinary bladder cancer	0.00102	0.00479	CbGeAlD
L-Glutamine—SLC7A8—renal system—urinary bladder cancer	0.001	0.00472	CbGeAlD
L-Glutamine—ASNS—smooth muscle tissue—urinary bladder cancer	0.000995	0.00467	CbGeAlD
L-Glutamine—GLS2—lymph node—urinary bladder cancer	0.000979	0.0046	CbGeAlD
L-Glutamine—NADSYN1—lymph node—urinary bladder cancer	0.000979	0.0046	CbGeAlD
L-Glutamine—PPAT—female reproductive system—urinary bladder cancer	0.000965	0.00453	CbGeAlD
L-Glutamine—CAD—vagina—urinary bladder cancer	0.000941	0.00442	CbGeAlD
L-Glutamine—ASNS—urethra—urinary bladder cancer	0.000941	0.00442	CbGeAlD
L-Glutamine—Glutathione—HPGDS—urinary bladder cancer	0.000904	0.0921	CrCbGaD
L-Glutamine—CCBL1—lymph node—urinary bladder cancer	0.000899	0.00422	CbGeAlD
L-Glutamine—GATB—lymph node—urinary bladder cancer	0.000899	0.00422	CbGeAlD
L-Glutamine—SLC1A5—female reproductive system—urinary bladder cancer	0.000894	0.0042	CbGeAlD
L-Glutamine—SLC16A10—prostate gland—urinary bladder cancer	0.000875	0.00411	CbGeAlD
L-Glutamine—PPAT—vagina—urinary bladder cancer	0.000873	0.0041	CbGeAlD
L-Glutamine—GLS—lymph node—urinary bladder cancer	0.000846	0.00398	CbGeAlD
L-Glutamine—GLUL—epithelium—urinary bladder cancer	0.000843	0.00396	CbGeAlD
L-Glutamine—GLUL—smooth muscle tissue—urinary bladder cancer	0.000812	0.00382	CbGeAlD
L-Glutamine—SLC1A5—vagina—urinary bladder cancer	0.000808	0.0038	CbGeAlD
L-Glutamine—SLC7A8—female reproductive system—urinary bladder cancer	0.000805	0.00378	CbGeAlD
L-Glutamine—CTPS1—lymph node—urinary bladder cancer	0.000788	0.0037	CbGeAlD
L-Glutamine—GMPS—lymph node—urinary bladder cancer	0.000788	0.0037	CbGeAlD
L-Glutamine—GLUL—renal system—urinary bladder cancer	0.000782	0.00367	CbGeAlD
L-Glutamine—PFAS—lymph node—urinary bladder cancer	0.000774	0.00364	CbGeAlD
L-Glutamine—GFPT2—lymph node—urinary bladder cancer	0.000774	0.00364	CbGeAlD
L-Glutamine—GLUL—urethra—urinary bladder cancer	0.000768	0.00361	CbGeAlD
L-Glutamine—SLC7A8—vagina—urinary bladder cancer	0.000728	0.00342	CbGeAlD
L-Glutamine—F13A1—lymph node—urinary bladder cancer	0.000695	0.00326	CbGeAlD
L-Glutamine—ASNS—vagina—urinary bladder cancer	0.000694	0.00326	CbGeAlD
L-Glutamine—QARS—lymph node—urinary bladder cancer	0.00066	0.0031	CbGeAlD
L-Glutamine—SLC16A10—epithelium—urinary bladder cancer	0.000643	0.00302	CbGeAlD
L-Glutamine—GLUL—female reproductive system—urinary bladder cancer	0.000626	0.00294	CbGeAlD
L-Glutamine—CAD—lymph node—urinary bladder cancer	0.000609	0.00286	CbGeAlD
L-Glutamine—GLUL—vagina—urinary bladder cancer	0.000566	0.00266	CbGeAlD
L-Glutamine—PPAT—lymph node—urinary bladder cancer	0.000565	0.00265	CbGeAlD
L-Glutamine—SLC1A5—lymph node—urinary bladder cancer	0.000523	0.00246	CbGeAlD
L-Glutamine—Glutathione—GSTT1—urinary bladder cancer	0.000516	0.0526	CrCbGaD
L-Glutamine—SLC16A10—female reproductive system—urinary bladder cancer	0.000478	0.00224	CbGeAlD
L-Glutamine—SLC7A8—lymph node—urinary bladder cancer	0.000471	0.00221	CbGeAlD
L-Glutamine—ASNS—lymph node—urinary bladder cancer	0.000449	0.00211	CbGeAlD
L-Glutamine—Rhinitis—Gemcitabine—urinary bladder cancer	0.000446	0.00309	CcSEcCtD
L-Glutamine—Back pain—Thiotepa—urinary bladder cancer	0.000446	0.00308	CcSEcCtD
L-Glutamine—Nausea—Mitomycin—urinary bladder cancer	0.000444	0.00307	CcSEcCtD
L-Glutamine—Pharyngitis—Gemcitabine—urinary bladder cancer	0.000442	0.00306	CcSEcCtD
L-Glutamine—Glutathione—GSTM1—urinary bladder cancer	0.000441	0.045	CrCbGaD
L-Glutamine—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.00044	0.00304	CcSEcCtD
L-Glutamine—Rhinitis—Fluorouracil—urinary bladder cancer	0.000439	0.00304	CcSEcCtD
L-Glutamine—Urethral disorder—Gemcitabine—urinary bladder cancer	0.000437	0.00302	CcSEcCtD
L-Glutamine—Viral infection—Doxorubicin—urinary bladder cancer	0.000435	0.00301	CcSEcCtD
L-Glutamine—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000435	0.003	CcSEcCtD
L-Glutamine—SLC16A10—vagina—urinary bladder cancer	0.000432	0.00203	CbGeAlD
L-Glutamine—Injection site reaction—Epirubicin—urinary bladder cancer	0.000422	0.00292	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000415	0.00287	CcSEcCtD
L-Glutamine—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.00041	0.00283	CcSEcCtD
L-Glutamine—Glutathione—GSTP1—urinary bladder cancer	0.000408	0.0416	CrCbGaD
L-Glutamine—Urethral disorder—Cisplatin—urinary bladder cancer	0.000407	0.00281	CcSEcCtD
L-Glutamine—Candida infection—Epirubicin—urinary bladder cancer	0.000405	0.0028	CcSEcCtD
L-Glutamine—Angiopathy—Gemcitabine—urinary bladder cancer	0.000404	0.00279	CcSEcCtD
L-Glutamine—Chills—Gemcitabine—urinary bladder cancer	0.0004	0.00276	CcSEcCtD
L-Glutamine—Sepsis—Methotrexate—urinary bladder cancer	0.000394	0.00272	CcSEcCtD
L-Glutamine—Arthralgia—Thiotepa—urinary bladder cancer	0.000392	0.00271	CcSEcCtD
L-Glutamine—Myalgia—Thiotepa—urinary bladder cancer	0.000392	0.00271	CcSEcCtD
L-Glutamine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00039	0.0027	CcSEcCtD
L-Glutamine—Urinary tract disorder—Etoposide—urinary bladder cancer	0.000376	0.0026	CcSEcCtD
L-Glutamine—Back pain—Gemcitabine—urinary bladder cancer	0.000375	0.00259	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—urinary bladder cancer	0.000375	0.00259	CcSEcCtD
L-Glutamine—Infection—Thiotepa—urinary bladder cancer	0.000374	0.00258	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—urinary bladder cancer	0.000373	0.00258	CcSEcCtD
L-Glutamine—Sepsis—Epirubicin—urinary bladder cancer	0.000368	0.00255	CcSEcCtD
L-Glutamine—GLUL—lymph node—urinary bladder cancer	0.000366	0.00172	CbGeAlD
L-Glutamine—Malnutrition—Cisplatin—urinary bladder cancer	0.000361	0.0025	CcSEcCtD
L-Glutamine—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00036	0.00249	CcSEcCtD
L-Glutamine—Flatulence—Cisplatin—urinary bladder cancer	0.000356	0.00246	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.000353	0.00244	CcSEcCtD
L-Glutamine—Malaise—Gemcitabine—urinary bladder cancer	0.00035	0.00242	CcSEcCtD
L-Glutamine—Angiopathy—Etoposide—urinary bladder cancer	0.000345	0.00239	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000343	0.00237	CcSEcCtD
L-Glutamine—L-Methionine—MTHFR—urinary bladder cancer	0.000341	0.0348	CrCbGaD
L-Glutamine—Chills—Etoposide—urinary bladder cancer	0.000341	0.00236	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—urinary bladder cancer	0.000341	0.00236	CcSEcCtD
L-Glutamine—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000335	0.00232	CcSEcCtD
L-Glutamine—Chest pain—Gemcitabine—urinary bladder cancer	0.00033	0.00228	CcSEcCtD
L-Glutamine—Myalgia—Gemcitabine—urinary bladder cancer	0.00033	0.00228	CcSEcCtD
L-Glutamine—Arthralgia—Gemcitabine—urinary bladder cancer	0.00033	0.00228	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000326	0.00226	CcSEcCtD
L-Glutamine—Discomfort—Gemcitabine—urinary bladder cancer	0.000326	0.00225	CcSEcCtD
L-Glutamine—Malaise—Cisplatin—urinary bladder cancer	0.000326	0.00225	CcSEcCtD
L-Glutamine—Myalgia—Fluorouracil—urinary bladder cancer	0.000324	0.00224	CcSEcCtD
L-Glutamine—Chest pain—Fluorouracil—urinary bladder cancer	0.000324	0.00224	CcSEcCtD
L-Glutamine—Fatigue—Thiotepa—urinary bladder cancer	0.000324	0.00224	CcSEcCtD
L-Glutamine—Pain—Thiotepa—urinary bladder cancer	0.000322	0.00222	CcSEcCtD
L-Glutamine—Constipation—Thiotepa—urinary bladder cancer	0.000322	0.00222	CcSEcCtD
L-Glutamine—Discomfort—Fluorouracil—urinary bladder cancer	0.000321	0.00222	CcSEcCtD
L-Glutamine—Back pain—Etoposide—urinary bladder cancer	0.00032	0.00221	CcSEcCtD
L-Glutamine—Oedema—Gemcitabine—urinary bladder cancer	0.000316	0.00219	CcSEcCtD
L-Glutamine—Infection—Gemcitabine—urinary bladder cancer	0.000314	0.00217	CcSEcCtD
L-Glutamine—Oedema—Fluorouracil—urinary bladder cancer	0.000311	0.00215	CcSEcCtD
L-Glutamine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00031	0.00214	CcSEcCtD
L-Glutamine—Infection—Fluorouracil—urinary bladder cancer	0.000309	0.00214	CcSEcCtD
L-Glutamine—Myalgia—Cisplatin—urinary bladder cancer	0.000308	0.00213	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000308	0.00213	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000307	0.00212	CcSEcCtD
L-Glutamine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000306	0.00211	CcSEcCtD
L-Glutamine—Discomfort—Cisplatin—urinary bladder cancer	0.000304	0.0021	CcSEcCtD
L-Glutamine—Malaise—Etoposide—urinary bladder cancer	0.000299	0.00206	CcSEcCtD
L-Glutamine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000297	0.00206	CcSEcCtD
L-Glutamine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000297	0.00206	CcSEcCtD
L-Glutamine—Oedema—Cisplatin—urinary bladder cancer	0.000295	0.00204	CcSEcCtD
L-Glutamine—Infection—Cisplatin—urinary bladder cancer	0.000293	0.00203	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000288	0.00199	CcSEcCtD
L-Glutamine—Dehydration—Epirubicin—urinary bladder cancer	0.000287	0.00198	CcSEcCtD
L-Glutamine—Insomnia—Gemcitabine—urinary bladder cancer	0.000286	0.00198	CcSEcCtD
L-Glutamine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000285	0.00197	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000283	0.00196	CcSEcCtD
L-Glutamine—Chest pain—Etoposide—urinary bladder cancer	0.000282	0.00195	CcSEcCtD
L-Glutamine—Insomnia—Fluorouracil—urinary bladder cancer	0.000281	0.00195	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—urinary bladder cancer	0.000279	0.00131	CbGeAlD
L-Glutamine—Pancreatitis—Methotrexate—urinary bladder cancer	0.000279	0.00193	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—urinary bladder cancer	0.000278	0.00193	CcSEcCtD
L-Glutamine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000277	0.00192	CcSEcCtD
L-Glutamine—Fatigue—Gemcitabine—urinary bladder cancer	0.000273	0.00189	CcSEcCtD
L-Glutamine—Pain—Gemcitabine—urinary bladder cancer	0.000271	0.00187	CcSEcCtD
L-Glutamine—Constipation—Gemcitabine—urinary bladder cancer	0.000271	0.00187	CcSEcCtD
L-Glutamine—Asthenia—Thiotepa—urinary bladder cancer	0.00027	0.00187	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000269	0.00186	CcSEcCtD
L-Glutamine—Infection—Etoposide—urinary bladder cancer	0.000268	0.00186	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—urinary bladder cancer	0.000268	0.00185	CcSEcCtD
L-Glutamine—Pruritus—Thiotepa—urinary bladder cancer	0.000266	0.00184	CcSEcCtD
L-Glutamine—Pain—Fluorouracil—urinary bladder cancer	0.000266	0.00184	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—urinary bladder cancer	0.000265	0.00183	CcSEcCtD
L-Glutamine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000261	0.00181	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000261	0.00181	CcSEcCtD
L-Glutamine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000261	0.0018	CcSEcCtD
L-Glutamine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000256	0.00177	CcSEcCtD
L-Glutamine—Depression—Methotrexate—urinary bladder cancer	0.000253	0.00175	CcSEcCtD
L-Glutamine—Pain—Cisplatin—urinary bladder cancer	0.000252	0.00174	CcSEcCtD
L-Glutamine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00025	0.00173	CcSEcCtD
L-Glutamine—Dizziness—Thiotepa—urinary bladder cancer	0.000249	0.00172	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000248	0.00172	CcSEcCtD
L-Glutamine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000246	0.0017	CcSEcCtD
L-Glutamine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000243	0.00168	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000242	0.00167	CcSEcCtD
L-Glutamine—Vomiting—Thiotepa—urinary bladder cancer	0.000239	0.00165	CcSEcCtD
L-Glutamine—Rash—Thiotepa—urinary bladder cancer	0.000237	0.00164	CcSEcCtD
L-Glutamine—Dermatitis—Thiotepa—urinary bladder cancer	0.000237	0.00164	CcSEcCtD
L-Glutamine—Headache—Thiotepa—urinary bladder cancer	0.000236	0.00163	CcSEcCtD
L-Glutamine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000233	0.00161	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—urinary bladder cancer	0.000233	0.00161	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000233	0.00161	CcSEcCtD
L-Glutamine—Constipation—Etoposide—urinary bladder cancer	0.000231	0.0016	CcSEcCtD
L-Glutamine—Pain—Etoposide—urinary bladder cancer	0.000231	0.0016	CcSEcCtD
L-Glutamine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000229	0.00158	CcSEcCtD
L-Glutamine—Asthenia—Gemcitabine—urinary bladder cancer	0.000227	0.00157	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000226	0.00156	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000225	0.00156	CcSEcCtD
L-Glutamine—Pruritus—Gemcitabine—urinary bladder cancer	0.000224	0.00155	CcSEcCtD
L-Glutamine—Nausea—Thiotepa—urinary bladder cancer	0.000223	0.00154	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000223	0.00154	CcSEcCtD
L-Glutamine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000223	0.00154	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000221	0.00153	CcSEcCtD
L-Glutamine—Pruritus—Fluorouracil—urinary bladder cancer	0.00022	0.00152	CcSEcCtD
L-Glutamine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000217	0.0015	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000215	0.00149	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—urinary bladder cancer	0.000214	0.00148	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—urinary bladder cancer	0.000214	0.00148	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—urinary bladder cancer	0.000214	0.00148	CcSEcCtD
L-Glutamine—Asthenia—Cisplatin—urinary bladder cancer	0.000212	0.00146	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000212	0.00146	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00021	0.00146	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000209	0.00144	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—urinary bladder cancer	0.000207	0.00143	CcSEcCtD
L-Glutamine—Dizziness—Fluorouracil—urinary bladder cancer	0.000206	0.00142	CcSEcCtD
L-Glutamine—Chills—Methotrexate—urinary bladder cancer	0.000204	0.00141	CcSEcCtD
L-Glutamine—Vomiting—Gemcitabine—urinary bladder cancer	0.000201	0.00139	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—urinary bladder cancer	0.0002	0.00138	CcSEcCtD
L-Glutamine—Rash—Gemcitabine—urinary bladder cancer	0.000199	0.00138	CcSEcCtD
L-Glutamine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000199	0.00138	CcSEcCtD
L-Glutamine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000199	0.00138	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—urinary bladder cancer	0.000198	0.00137	CcSEcCtD
L-Glutamine—Headache—Gemcitabine—urinary bladder cancer	0.000198	0.00137	CcSEcCtD
L-Glutamine—Vomiting—Fluorouracil—urinary bladder cancer	0.000198	0.00137	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000198	0.00137	CcSEcCtD
L-Glutamine—Rash—Fluorouracil—urinary bladder cancer	0.000196	0.00136	CcSEcCtD
L-Glutamine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000196	0.00135	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000196	0.00135	CcSEcCtD
L-Glutamine—Headache—Fluorouracil—urinary bladder cancer	0.000195	0.00135	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000195	0.00135	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—urinary bladder cancer	0.000194	0.00134	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—urinary bladder cancer	0.000193	0.00134	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000193	0.00134	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—urinary bladder cancer	0.000192	0.00133	CcSEcCtD
L-Glutamine—Chills—Epirubicin—urinary bladder cancer	0.000191	0.00132	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—urinary bladder cancer	0.000191	0.00132	CcSEcCtD
L-Glutamine—Nausea—Gemcitabine—urinary bladder cancer	0.000188	0.0013	CcSEcCtD
L-Glutamine—Vomiting—Cisplatin—urinary bladder cancer	0.000187	0.0013	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—urinary bladder cancer	0.000187	0.00129	CcSEcCtD
L-Glutamine—Rash—Cisplatin—urinary bladder cancer	0.000186	0.00129	CcSEcCtD
L-Glutamine—Dermatitis—Cisplatin—urinary bladder cancer	0.000186	0.00128	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—urinary bladder cancer	0.000186	0.00128	CcSEcCtD
L-Glutamine—Nausea—Fluorouracil—urinary bladder cancer	0.000185	0.00128	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000184	0.00127	CcSEcCtD
L-Glutamine—Flatulence—Epirubicin—urinary bladder cancer	0.000183	0.00126	CcSEcCtD
L-Glutamine—Back pain—Epirubicin—urinary bladder cancer	0.000179	0.00124	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000179	0.00124	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—urinary bladder cancer	0.000179	0.00124	CcSEcCtD
L-Glutamine—Dizziness—Etoposide—urinary bladder cancer	0.000179	0.00124	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—urinary bladder cancer	0.000177	0.00122	CcSEcCtD
L-Glutamine—Nausea—Cisplatin—urinary bladder cancer	0.000175	0.00121	CcSEcCtD
L-Glutamine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000173	0.00119	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000172	0.00119	CcSEcCtD
L-Glutamine—Vomiting—Etoposide—urinary bladder cancer	0.000172	0.00119	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000172	0.00119	CcSEcCtD
L-Glutamine—Rash—Etoposide—urinary bladder cancer	0.00017	0.00118	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—urinary bladder cancer	0.00017	0.00118	CcSEcCtD
L-Glutamine—Headache—Etoposide—urinary bladder cancer	0.000169	0.00117	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—urinary bladder cancer	0.000169	0.00117	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—urinary bladder cancer	0.000169	0.00117	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—urinary bladder cancer	0.000169	0.00117	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—urinary bladder cancer	0.000169	0.00117	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—urinary bladder cancer	0.000167	0.00116	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—urinary bladder cancer	0.000167	0.00115	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—urinary bladder cancer	0.000166	0.00115	CcSEcCtD
L-Glutamine—Infection—Methotrexate—urinary bladder cancer	0.000161	0.00111	CcSEcCtD
L-Glutamine—Nausea—Etoposide—urinary bladder cancer	0.00016	0.00111	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000159	0.0011	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—urinary bladder cancer	0.000158	0.00109	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—urinary bladder cancer	0.000158	0.00109	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—urinary bladder cancer	0.000158	0.00109	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000156	0.00108	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—urinary bladder cancer	0.000156	0.00108	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—urinary bladder cancer	0.000155	0.00107	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—urinary bladder cancer	0.000154	0.00107	CcSEcCtD
L-Glutamine—Oedema—Epirubicin—urinary bladder cancer	0.000151	0.00105	CcSEcCtD
L-Glutamine—Infection—Epirubicin—urinary bladder cancer	0.00015	0.00104	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000147	0.00102	CcSEcCtD
L-Glutamine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000146	0.00101	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—urinary bladder cancer	0.000146	0.00101	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—urinary bladder cancer	0.000146	0.00101	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—urinary bladder cancer	0.000146	0.00101	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000146	0.00101	CcSEcCtD
L-Glutamine—Discomfort—Doxorubicin—urinary bladder cancer	0.000144	0.000999	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000143	0.000988	CcSEcCtD
L-Glutamine—Oedema—Doxorubicin—urinary bladder cancer	0.00014	0.000969	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—urinary bladder cancer	0.00014	0.000965	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—urinary bladder cancer	0.000139	0.000963	CcSEcCtD
L-Glutamine—Pain—Methotrexate—urinary bladder cancer	0.000138	0.000957	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000138	0.000954	CcSEcCtD
L-Glutamine—Insomnia—Epirubicin—urinary bladder cancer	0.000137	0.000947	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000135	0.000937	CcSEcCtD
L-Glutamine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000133	0.000922	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000132	0.000915	CcSEcCtD
L-Glutamine—Fatigue—Epirubicin—urinary bladder cancer	0.000131	0.000903	CcSEcCtD
L-Glutamine—Pain—Epirubicin—urinary bladder cancer	0.000129	0.000895	CcSEcCtD
L-Glutamine—Constipation—Epirubicin—urinary bladder cancer	0.000129	0.000895	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000128	0.000885	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000128	0.000885	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000128	0.000883	CcSEcCtD
L-Glutamine—Insomnia—Doxorubicin—urinary bladder cancer	0.000127	0.000876	CcSEcCtD
L-Glutamine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000125	0.000863	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000124	0.000856	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—urinary bladder cancer	0.000121	0.000835	CcSEcCtD
L-Glutamine—CAD—Metabolism—NAT2—urinary bladder cancer	0.00012	0.000739	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NQO1—urinary bladder cancer	0.00012	0.000739	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NQO1—urinary bladder cancer	0.00012	0.000739	CbGpPWpGaD
L-Glutamine—Constipation—Doxorubicin—urinary bladder cancer	0.00012	0.000829	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—urinary bladder cancer	0.00012	0.000829	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00012	0.000828	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00012	0.000828	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000119	0.000824	CcSEcCtD
L-Glutamine—GLS—Metabolism—ENO2—urinary bladder cancer	0.000119	0.000733	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—HPGDS—urinary bladder cancer	0.000119	0.000733	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—HPGDS—urinary bladder cancer	0.000119	0.000733	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ENO2—urinary bladder cancer	0.000119	0.000733	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ENO2—urinary bladder cancer	0.000119	0.000733	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—HPGDS—urinary bladder cancer	0.000119	0.000733	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—CREBBP—urinary bladder cancer	0.000118	0.000729	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—NCOR1—urinary bladder cancer	0.000118	0.000729	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PRSS3—urinary bladder cancer	0.000118	0.000729	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PRSS3—urinary bladder cancer	0.000118	0.000729	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—IGF1—urinary bladder cancer	0.000117	0.00072	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.000117	0.00072	CbGpPWpGaD
L-Glutamine—Asthenia—Methotrexate—urinary bladder cancer	0.000116	0.000803	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—IFNA2—urinary bladder cancer	0.000116	0.000715	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000115	0.000798	CcSEcCtD
L-Glutamine—GLS2—Metabolism—GSTT1—urinary bladder cancer	0.000115	0.000711	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTT1—urinary bladder cancer	0.000115	0.000711	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTT1—urinary bladder cancer	0.000115	0.000711	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000115	0.000792	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—urinary bladder cancer	0.000114	0.000792	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GSTP1—urinary bladder cancer	0.000112	0.000692	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000112	0.000772	CcSEcCtD
L-Glutamine—QARS—Gene Expression—ERCC2—urinary bladder cancer	0.000111	0.000685	CbGpPWpGaD
L-Glutamine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000111	0.000766	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000111	0.000766	CcSEcCtD
L-Glutamine—PPAT—Metabolism—NAT2—urinary bladder cancer	0.00011	0.000676	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NQO1—urinary bladder cancer	0.00011	0.000676	CbGpPWpGaD
L-Glutamine—Asthenia—Epirubicin—urinary bladder cancer	0.000109	0.000751	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000108	0.000665	CbGpPWpGaD
L-Glutamine—Pruritus—Epirubicin—urinary bladder cancer	0.000107	0.000741	CcSEcCtD
L-Glutamine—Dizziness—Methotrexate—urinary bladder cancer	0.000107	0.00074	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—RHOA—urinary bladder cancer	0.000107	0.00066	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—TYMS—urinary bladder cancer	0.000104	0.000643	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—RRM2—urinary bladder cancer	0.000103	0.000638	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000103	0.000714	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GSTM1—urinary bladder cancer	0.000103	0.000636	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—NCOR1—urinary bladder cancer	0.000103	0.000636	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—IGF1—urinary bladder cancer	0.000103	0.000635	CbGpPWpGaD
L-Glutamine—Vomiting—Methotrexate—urinary bladder cancer	0.000103	0.000711	CcSEcCtD
L-Glutamine—Rash—Methotrexate—urinary bladder cancer	0.000102	0.000706	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—urinary bladder cancer	0.000102	0.000705	CcSEcCtD
L-Glutamine—Headache—Methotrexate—urinary bladder cancer	0.000101	0.000701	CcSEcCtD
L-Glutamine—Asthenia—Doxorubicin—urinary bladder cancer	0.000101	0.000695	CcSEcCtD
L-Glutamine—NADSYN1—Disease—NCOR1—urinary bladder cancer	0.0001	0.000619	CbGpPWpGaD
L-Glutamine—Dizziness—Epirubicin—urinary bladder cancer	0.0001	0.000692	CcSEcCtD
L-Glutamine—PFAS—Metabolism—GSTP1—urinary bladder cancer	9.99e-05	0.000617	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GSTP1—urinary bladder cancer	9.99e-05	0.000617	CbGpPWpGaD
L-Glutamine—Pruritus—Doxorubicin—urinary bladder cancer	9.91e-05	0.000686	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GPX1—urinary bladder cancer	9.87e-05	0.000609	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—ERCC2—urinary bladder cancer	9.69e-05	0.000598	CbGpPWpGaD
L-Glutamine—Vomiting—Epirubicin—urinary bladder cancer	9.63e-05	0.000666	CcSEcCtD
L-Glutamine—Nausea—Methotrexate—urinary bladder cancer	9.61e-05	0.000665	CcSEcCtD
L-Glutamine—CAD—Metabolism—ENO2—urinary bladder cancer	9.58e-05	0.000591	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—HPGDS—urinary bladder cancer	9.58e-05	0.000591	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NQO1—urinary bladder cancer	9.58e-05	0.000591	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NQO1—urinary bladder cancer	9.58e-05	0.000591	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NQO1—urinary bladder cancer	9.58e-05	0.000591	CbGpPWpGaD
L-Glutamine—Rash—Epirubicin—urinary bladder cancer	9.55e-05	0.00066	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—urinary bladder cancer	9.54e-05	0.00066	CcSEcCtD
L-Glutamine—Headache—Epirubicin—urinary bladder cancer	9.49e-05	0.000656	CcSEcCtD
L-Glutamine—PPAT—Metabolism—RRM2—urinary bladder cancer	9.46e-05	0.000584	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TYMP—urinary bladder cancer	9.44e-05	0.000582	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TYMP—urinary bladder cancer	9.44e-05	0.000582	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERCC2—urinary bladder cancer	9.43e-05	0.000582	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.36e-05	0.000577	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—HRAS—urinary bladder cancer	9.36e-05	0.000577	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—urinary bladder cancer	9.36e-05	0.000577	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTT1—urinary bladder cancer	9.29e-05	0.000573	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—TYMS—urinary bladder cancer	9.29e-05	0.000573	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—TYMS—urinary bladder cancer	9.29e-05	0.000573	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—ESR1—urinary bladder cancer	9.28e-05	0.000572	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—urinary bladder cancer	9.27e-05	0.000641	CcSEcCtD
L-Glutamine—PFAS—Metabolism—NCOR1—urinary bladder cancer	9.18e-05	0.000567	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NCOR1—urinary bladder cancer	9.18e-05	0.000567	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GSTM1—urinary bladder cancer	9.18e-05	0.000567	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—GSTM1—urinary bladder cancer	9.18e-05	0.000567	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GSTP1—urinary bladder cancer	9.14e-05	0.000564	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—MTHFR—urinary bladder cancer	9.11e-05	0.000562	CbGpPWpGaD
L-Glutamine—Nausea—Epirubicin—urinary bladder cancer	8.99e-05	0.000622	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—IL2—urinary bladder cancer	8.97e-05	0.000553	CbGpPWpGaD
L-Glutamine—Vomiting—Doxorubicin—urinary bladder cancer	8.91e-05	0.000616	CcSEcCtD
L-Glutamine—NADSYN1—Disease—MTHFR—urinary bladder cancer	8.86e-05	0.000547	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TERT—urinary bladder cancer	8.84e-05	0.000545	CbGpPWpGaD
L-Glutamine—Rash—Doxorubicin—urinary bladder cancer	8.83e-05	0.000611	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—urinary bladder cancer	8.83e-05	0.00061	CcSEcCtD
L-Glutamine—PFAS—Metabolism—GPX1—urinary bladder cancer	8.8e-05	0.000543	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GPX1—urinary bladder cancer	8.8e-05	0.000543	CbGpPWpGaD
L-Glutamine—Headache—Doxorubicin—urinary bladder cancer	8.78e-05	0.000607	CcSEcCtD
L-Glutamine—CCBL1—Disease—NCOR1—urinary bladder cancer	8.77e-05	0.000541	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—HPGDS—urinary bladder cancer	8.76e-05	0.00054	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ENO2—urinary bladder cancer	8.76e-05	0.00054	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ERCC2—urinary bladder cancer	8.64e-05	0.000533	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ERCC2—urinary bladder cancer	8.64e-05	0.000533	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NAT2—urinary bladder cancer	8.54e-05	0.000527	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NAT2—urinary bladder cancer	8.54e-05	0.000527	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTT1—urinary bladder cancer	8.5e-05	0.000524	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—TYMS—urinary bladder cancer	8.5e-05	0.000524	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—PPARG—urinary bladder cancer	8.47e-05	0.000522	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GSTM1—urinary bladder cancer	8.4e-05	0.000518	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NCOR1—urinary bladder cancer	8.4e-05	0.000518	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—urinary bladder cancer	8.32e-05	0.000576	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—CXCL8—urinary bladder cancer	8.28e-05	0.000511	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERCC2—urinary bladder cancer	8.24e-05	0.000508	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PLAU—urinary bladder cancer	8.23e-05	0.000508	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—CREBBP—urinary bladder cancer	8.13e-05	0.000502	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—MTHFR—urinary bladder cancer	8.12e-05	0.000501	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—MTHFR—urinary bladder cancer	8.12e-05	0.000501	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FGFR3—urinary bladder cancer	8.11e-05	0.0005	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—EP300—urinary bladder cancer	8.05e-05	0.000497	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GPX1—urinary bladder cancer	8.04e-05	0.000496	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTP1—urinary bladder cancer	7.99e-05	0.000493	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTP1—urinary bladder cancer	7.99e-05	0.000493	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTP1—urinary bladder cancer	7.99e-05	0.000493	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.96e-05	0.000491	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ERCC2—urinary bladder cancer	7.9e-05	0.000487	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—SRC—urinary bladder cancer	7.83e-05	0.000483	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTHFR—urinary bladder cancer	7.75e-05	0.000478	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TERT—urinary bladder cancer	7.73e-05	0.000477	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NQO1—urinary bladder cancer	7.72e-05	0.000476	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—TYMS—urinary bladder cancer	7.43e-05	0.000458	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—TYMS—urinary bladder cancer	7.43e-05	0.000458	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—TYMS—urinary bladder cancer	7.43e-05	0.000458	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—MTHFR—urinary bladder cancer	7.42e-05	0.000458	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PPARG—urinary bladder cancer	7.39e-05	0.000456	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—RRM2—urinary bladder cancer	7.37e-05	0.000455	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—RRM2—urinary bladder cancer	7.37e-05	0.000455	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTM1—urinary bladder cancer	7.34e-05	0.000453	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTM1—urinary bladder cancer	7.34e-05	0.000453	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTM1—urinary bladder cancer	7.34e-05	0.000453	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NCOR1—urinary bladder cancer	7.34e-05	0.000453	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NCOR1—urinary bladder cancer	7.34e-05	0.000453	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NCOR1—urinary bladder cancer	7.34e-05	0.000453	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.28e-05	0.000449	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CREBBP—urinary bladder cancer	7.09e-05	0.000438	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FGFR3—urinary bladder cancer	7.09e-05	0.000437	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NQO1—urinary bladder cancer	7.06e-05	0.000436	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GPX1—urinary bladder cancer	7.03e-05	0.000434	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GPX1—urinary bladder cancer	7.03e-05	0.000434	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GPX1—urinary bladder cancer	7.03e-05	0.000434	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.01e-05	0.000433	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CREBBP—urinary bladder cancer	6.91e-05	0.000426	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ERCC2—urinary bladder cancer	6.9e-05	0.000426	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ERCC2—urinary bladder cancer	6.9e-05	0.000426	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ERCC2—urinary bladder cancer	6.9e-05	0.000426	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HPGDS—urinary bladder cancer	6.83e-05	0.000421	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HPGDS—urinary bladder cancer	6.83e-05	0.000421	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—urinary bladder cancer	6.83e-05	0.000421	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—urinary bladder cancer	6.83e-05	0.000421	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—CREBBP—urinary bladder cancer	6.79e-05	0.000419	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IGF1—urinary bladder cancer	6.7e-05	0.000414	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTT1—urinary bladder cancer	6.62e-05	0.000408	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTT1—urinary bladder cancer	6.62e-05	0.000408	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PPARG—urinary bladder cancer	6.58e-05	0.000406	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PPARG—urinary bladder cancer	6.58e-05	0.000406	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—MTHFR—urinary bladder cancer	6.49e-05	0.0004	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—MTHFR—urinary bladder cancer	6.49e-05	0.0004	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—MTHFR—urinary bladder cancer	6.49e-05	0.0004	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—urinary bladder cancer	6.48e-05	0.0004	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTP1—urinary bladder cancer	6.44e-05	0.000397	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CREBBP—urinary bladder cancer	6.32e-05	0.00039	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CREBBP—urinary bladder cancer	6.32e-05	0.00039	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—RHOA—urinary bladder cancer	6.25e-05	0.000385	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—RHOA—urinary bladder cancer	6.14e-05	0.000379	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CREBBP—urinary bladder cancer	6.04e-05	0.000372	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PPARG—urinary bladder cancer	6.02e-05	0.000371	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—TYMS—urinary bladder cancer	5.99e-05	0.000369	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NCOR1—urinary bladder cancer	5.92e-05	0.000365	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTM1—urinary bladder cancer	5.92e-05	0.000365	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTP1—urinary bladder cancer	5.89e-05	0.000363	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.88e-05	0.000362	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—urinary bladder cancer	5.81e-05	0.000358	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CREBBP—urinary bladder cancer	5.78e-05	0.000357	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—urinary bladder cancer	5.78e-05	0.000357	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—urinary bladder cancer	5.76e-05	0.000355	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GPX1—urinary bladder cancer	5.67e-05	0.00035	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—urinary bladder cancer	5.65e-05	0.000349	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ERCC2—urinary bladder cancer	5.56e-05	0.000343	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—IGF1—urinary bladder cancer	5.56e-05	0.000343	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—urinary bladder cancer	5.51e-05	0.00034	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NQO1—urinary bladder cancer	5.5e-05	0.000339	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NQO1—urinary bladder cancer	5.5e-05	0.000339	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—TYMS—urinary bladder cancer	5.48e-05	0.000338	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—RHOA—urinary bladder cancer	5.46e-05	0.000337	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NCOR1—urinary bladder cancer	5.41e-05	0.000334	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTM1—urinary bladder cancer	5.41e-05	0.000334	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—urinary bladder cancer	5.37e-05	0.000332	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PPARG—urinary bladder cancer	5.26e-05	0.000325	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PPARG—urinary bladder cancer	5.26e-05	0.000325	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PPARG—urinary bladder cancer	5.26e-05	0.000325	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—MTHFR—urinary bladder cancer	5.23e-05	0.000323	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GPX1—urinary bladder cancer	5.18e-05	0.00032	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—urinary bladder cancer	5.18e-05	0.000319	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—urinary bladder cancer	5.18e-05	0.000319	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—urinary bladder cancer	5.15e-05	0.000318	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ERCC2—urinary bladder cancer	5.09e-05	0.000314	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—urinary bladder cancer	5.07e-05	0.000313	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CREBBP—urinary bladder cancer	5.06e-05	0.000312	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CREBBP—urinary bladder cancer	5.06e-05	0.000312	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CREBBP—urinary bladder cancer	5.06e-05	0.000312	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—urinary bladder cancer	5.06e-05	0.000312	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1A—urinary bladder cancer	4.94e-05	0.000305	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—urinary bladder cancer	4.94e-05	0.000305	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—urinary bladder cancer	4.93e-05	0.000304	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—EP300—urinary bladder cancer	4.83e-05	0.000298	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—urinary bladder cancer	4.83e-05	0.000298	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—MTHFR—urinary bladder cancer	4.78e-05	0.000295	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—urinary bladder cancer	4.74e-05	0.000292	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EP300—urinary bladder cancer	4.7e-05	0.00029	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—EP300—urinary bladder cancer	4.62e-05	0.000285	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTP1—urinary bladder cancer	4.59e-05	0.000283	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTP1—urinary bladder cancer	4.59e-05	0.000283	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SRC—urinary bladder cancer	4.57e-05	0.000282	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—urinary bladder cancer	4.52e-05	0.000279	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—urinary bladder cancer	4.52e-05	0.000279	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—SRC—urinary bladder cancer	4.5e-05	0.000277	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CXCL8—urinary bladder cancer	4.47e-05	0.000276	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1A—urinary bladder cancer	4.32e-05	0.000267	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—urinary bladder cancer	4.31e-05	0.000266	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—EP300—urinary bladder cancer	4.31e-05	0.000266	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—EP300—urinary bladder cancer	4.31e-05	0.000266	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TYMS—urinary bladder cancer	4.27e-05	0.000263	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TYMS—urinary bladder cancer	4.27e-05	0.000263	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PPARG—urinary bladder cancer	4.24e-05	0.000262	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NCOR1—urinary bladder cancer	4.22e-05	0.00026	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTM1—urinary bladder cancer	4.22e-05	0.00026	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NCOR1—urinary bladder cancer	4.22e-05	0.00026	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTM1—urinary bladder cancer	4.22e-05	0.00026	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—urinary bladder cancer	4.14e-05	0.000255	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—urinary bladder cancer	4.14e-05	0.000255	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—urinary bladder cancer	4.14e-05	0.000255	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—urinary bladder cancer	4.13e-05	0.000255	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EP300—urinary bladder cancer	4.11e-05	0.000254	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—urinary bladder cancer	4.1e-05	0.000253	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CREBBP—urinary bladder cancer	4.07e-05	0.000251	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GPX1—urinary bladder cancer	4.04e-05	0.000249	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GPX1—urinary bladder cancer	4.04e-05	0.000249	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—urinary bladder cancer	4.01e-05	0.000247	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SRC—urinary bladder cancer	4e-05	0.000247	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ERCC2—urinary bladder cancer	3.97e-05	0.000245	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ERCC2—urinary bladder cancer	3.97e-05	0.000245	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—EP300—urinary bladder cancer	3.94e-05	0.000243	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PPARG—urinary bladder cancer	3.88e-05	0.000239	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—urinary bladder cancer	3.79e-05	0.000234	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MTHFR—urinary bladder cancer	3.73e-05	0.00023	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MTHFR—urinary bladder cancer	3.73e-05	0.00023	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CREBBP—urinary bladder cancer	3.73e-05	0.00023	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—urinary bladder cancer	3.72e-05	0.00023	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—urinary bladder cancer	3.61e-05	0.000223	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—urinary bladder cancer	3.61e-05	0.000223	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—urinary bladder cancer	3.61e-05	0.000223	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—urinary bladder cancer	3.58e-05	0.000221	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—urinary bladder cancer	3.5e-05	0.000216	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—EP300—urinary bladder cancer	3.44e-05	0.000212	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—EP300—urinary bladder cancer	3.44e-05	0.000212	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—EP300—urinary bladder cancer	3.44e-05	0.000212	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.41e-05	0.00021	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—urinary bladder cancer	3.34e-05	0.000206	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—urinary bladder cancer	3.31e-05	0.000204	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—urinary bladder cancer	3.31e-05	0.000204	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—urinary bladder cancer	3.22e-05	0.000199	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—urinary bladder cancer	3.16e-05	0.000195	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—urinary bladder cancer	3.05e-05	0.000188	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PPARG—urinary bladder cancer	3.02e-05	0.000186	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PPARG—urinary bladder cancer	3.02e-05	0.000186	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—urinary bladder cancer	2.91e-05	0.000179	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CREBBP—urinary bladder cancer	2.9e-05	0.000179	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CREBBP—urinary bladder cancer	2.9e-05	0.000179	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—urinary bladder cancer	2.81e-05	0.000174	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—EP300—urinary bladder cancer	2.78e-05	0.000171	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—urinary bladder cancer	2.66e-05	0.000164	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—EP300—urinary bladder cancer	2.54e-05	0.000157	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—urinary bladder cancer	2.38e-05	0.000147	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—urinary bladder cancer	2.38e-05	0.000147	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—urinary bladder cancer	2.07e-05	0.000128	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—urinary bladder cancer	2.07e-05	0.000128	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—EP300—urinary bladder cancer	1.98e-05	0.000122	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—EP300—urinary bladder cancer	1.98e-05	0.000122	CbGpPWpGaD
